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http:WHAT THIS PAPER ADDS
An angiosome is a block of tissue supplied by a speciﬁc artery comprising of skin, subcutaneous tissue, fascia,
muscle, and bone. The foot and ankle comprise six angiosomes, supplied via the tibial vessels. Revascularisation
of tibial vessels (via surgical or endovascular means) for localised tissue loss can be performed directly to the
affected angiosome (direct revascularisation [DR]), or not (indirect revascularisation [IR]). This systematic review
and meta-analysis shows that DR appears to result in improved wound healing and limb salvage rates compared
with IR, with no difference in overall mortality or re-intervention rates.Objective: The aim of this systematic review was to evaluate outcomes of direct revascularisation (DR) versus
indirect revascularisation (IR) of infrapopliteal arteries to the affected angiosome for critical limb ischaemia. Both
open and endovascular techniques were included.
Methods: A systematic review of key electronic journal databases was undertaken from inception to 22 March
2014. Studies comparing DR versus IR in patients with localised tissue loss were included. Meta-analysis was
performed for wound healing, limb salvage, mortality, and re-intervention rates, with numerous sensitivity
analyses. Quality of evidence was assessed using the Grading of Recommendations Assessment, Development
and Evaluation (GRADE) system.
Results: Fifteen cohort studies reporting on 1,868 individual limbs were included (endovascular revascularisation,
1,284 limbs; surgical revascularisation, 508 limbs; both methods, 76 limbs). GRADE quality of evidence was low or
very low for all outcomes. DR resulted in improved wound healing rates compared with IR (odds ratio [OR] 0.40,
95% conﬁdence interval [CI] 0.29e0.54) and improved limb salvage rates (OR 0.24, 95% CI 0.13e0.45), although
this latter effect was lost on high-quality study sensitivity analysis. Wound healing and limb salvage was improved
for both open and endovascular intervention. There was no effect on mortality (OR 0.77, 95% CI 0.50e1.19) or
reintervention rates (OR: 0.44, 95% CI 0.10e1.88).
Conclusion: DR of the tibial vessels appears to result in improved wound healing and limb salvage rates
compared with IR, with no effect on mortality or reintervention rates. However, the quality of evidence on which
these conclusions are based on is low.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Taylor and Palmer ﬁrst described the anatomical concept of
the angiosome as a block of tissue comprising of the skin,
subcutaneous tissue, fascia, muscle, and bone supplied by a
speciﬁc artery and drained by a speciﬁc vein.1 Of the 40
angiosomes in the body, the foot comprises has six, arising
from the posterior tibial artery (n ¼ 3), peroneal arteryresponding author.
il address: davebosanquet@hotmail.com (D.C. Bosanquet).
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//dx.doi.org/10.1016/j.ejvs.2014.04.002(n ¼ 2), and anterior tibial artery (n ¼ 1) (Fig. 1).2,3 Critical
limb ischaemia with disease affecting the infrapopliteal
vessels presents a well-recognised challenge to the vascular
surgeon and interventionist.4
When planning endovascular or open surgical interven-
tion, target vessel selection is typically dependent on the
quality of the outﬂow vessel and its run-off.5,6 Recent evi-
dence has suggested that direct revascularisation (DR) of
the ischaemic area (i.e., to the angiosome containing the
area of tissue loss) resulted in superior outcomes compared
with indirect revascularisation (IR) during endovascular
intervention.3,6e8 This is the same principle as restoring
inline ﬂow during open infrainguinal bypass surgery.5
Figure 1. Angiosomes of the foot and ankle. Three main arteries supply the six angiosomes of the foot and ankle. Left: The dorsum of the
foot and dorsum side of the toes are supplied by the anterior tibial artery (ATA) and dorsalis pedis artery. Middle: The posterior tibial
artery (PTA) is the major supply to the plantar aspect of the foot via three angiosomes comprising the calcaneal branch to the heel, the
medial plantar artery to the medial foot, and the lateral plantar artery to the lateral foot. Right: The lateral border of the ankle and the
outside of the heel is supplied by the peroneal artery (PA). Figure reproduced with permission from Iida et al.18
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collaterals are present, as angiosomal reperfusion will occur
via these collaterals.6e8
The evidence concerning the use IR and DR is considered
equivocal. While open surgical revascularisation is fairly
consistent, endovascular practice varies widely. The aim of
this systematic review was therefore to evaluate the out-
comes of both endovascular and open DR versus. IR of the
infrapopliteal vessels.METHODS
Data sources, search strategy, and selection criteria
A systematic review was undertaken utilising the Cochrane
collaboration speciﬁed protocol,9 and reported as per the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement for the conduct of
meta-analyses of interventional studies.10 The following
sources were searched without date restrictions: PubMed,
Embase, the Cochrane Library Database, and the Current
Controlled Trials register. Studies reporting comparisons of
DR versus IR in patients with critical limb ischaemia were
included. There was no limitation on publication type or
language. In the absence of an appropriately speciﬁc
Medical Subject Headings (MeSH) term, the free text search
term “angioso*” was used, which captured the following
search terms: angiosoma, angiosomal, angiosome, angio-
somes, angiosomic, angiosonics, angiosonographic, angio-
sonography, angiosonoplasty, and angiosorus. An extensive
search was also conducted using the “related articles”
function in PubMed, of which the results were limited to
human research published in the English language, with
review articles excluded. In addition, the European Journal
of Vascular and Endovascular Surgery, Journal of Vascular
Surgery, and British Journal of Surgery websites were
searched individually. The last search date was 22 March2014. Outcome events were captured when two or more
papers presented extractable data.
Studies reporting outcomes comparing DR with IR of the
infrapopliteal vessels in patients with critical limb ischaemia
of nontraumatic aetiology were included. Non-English lan-
guage papers were excluded, as were papers arising, or
suspected of arising, from duplicate publications.
Data extraction, outcome measures, and assessment of
study quality
Data extraction and assessment of methodological quality
was performed independently by two authors (DCB and
CPT). Where disagreement occurred, a consensus was
reached among all the authors. Extracted data consisted of
ﬁrst author, year of study, study type and design (including if
retrospective or prospective, single or multiple centres, if
consecutive patients were enrolled, how revascularisation
decisions were undertaken [if reviewers assessing if revas-
cularisation was DR or not were blinded]), number of par-
ticipants and individual limbs undergoing revascularisation,
duration of follow-up, modality of revascularisation (endo-
vascular or surgical bypass, bypass material used [vein vs.
vein and prosthetic material]), target vessel of revascular-
isation, and quality of study. Angiosomes were considered
grouped for tibial (“parent”) vessel revascularisation (i.e.,
n ¼ 3) and individually for pedal revascularisation (n ¼ 6). A
number of papers presented propensity matched data
owing to signiﬁcant baseline differences between patient
groups. Propensity-matched data were extracted preferen-
tially. Data were extracted at 1 year follow-up where
available, or, if not stated, at maximal follow-up.
Outcome measures were deﬁned as:
1. Wound healing rateddeﬁned as complete
epithelialisation of the target lesion with or without
adjunct intervention (e.g., debridement, grafting, etc.)
90 D.C. Bosanquet et al.2. Limb salvageddeﬁned as absence of major amputation
(i.e., proximal to the tarsometatarsal joint)
3. Mortality
4. Reintervention rate.
Outcomes were collected and analysed for individual
limbs, except for mortality, which was analysed for indi-
vidual patients, when data were available.
Study quality was assessed using the NewcastleeOttawa
(NO) score, which assigns points depending on the quality
of patient selection (maximum 4 points), comparability of
the cohort (maximum 2 points), and outcome assessment
(maximum 3 points).11 Studies with a score 6 were
considered to be of higher quality.
Statistical analysis and evidence rating
Meta-analysis was undertaken in RevMan version 5.2.6
(Nordic Cochrane Centre, Copenhagen, Denmark). Dichot-
omous data were analysed using odds ratio (OR) as the
summary statistic, and reported with 95% conﬁdence in-
tervals (CIs). When required, data were extracted from
KaplaneMeier curves by the methods described by Parmar
et al.12 Random-effects models using the ManteleHaenszel
method were used (assuming signiﬁcant heterogeneity be-
tween studies). Heterogeneity was assessed using an I2
calculation.
Sensitivity analysis was performed when more than two
studies were available for inclusion, and for the following
subgroups: endovascular treatment alone, surgical bypass
alone, larger studies (n < 100), those with propensity
matched groups, those with an NO score of 6, and those
with follow-up given at 1 year.
Rating of the quality of evidence and strength of
recommendation was undertaken using the Grading of
Recommendations Assessment, Development and Evalua-
tion (GRADE) system, as per Cochrane collaboration’s
recommendation.13 Quality was assessed depending on risk
of bias, indirectness of evidence, heterogeneity, imprecision
of results, and publication bias. Cohort studies, by deﬁni-
tion, have a “low” quality of evidence prior to further
quality assessment. The presence of one or more serious
limitations results in a “very low” grade of evidence. A
serious effect on quality of evidence was considered to
occur when >50% of included papers evidenced a risk of
bias. Inconsistency was deﬁned as an I2 of >50%. Indi-
rectness was assumed not to occur in this setting. Impre-
cision was deﬁned as fewer than 50 patients in either
cohort. A serious effect on quality of evidence was
considered to occur when >50% of included papers evi-
denced a risk of imprecision. Publication bias was assessed
using funnel plots for outcomes with >10 studies.14
RESULTS
Paper search and selection process
The initial search yielded 1,348 results, of which 31 papers
were retrieved for full evaluation. Eight conference pro-
ceedings were included within this full evaluation. Fifteenpapers (of which two were conference proceedings) fulﬁlled
the inclusion criteria and were included in the subsequent
review (Fig. 2).15e29 Excluded papers of note included four
duplicate publications30e33 and one paper in which the data
were nonextractable.34 All included papers were cohort
studies comparing outcomes of DR to the angiosome (or
angiosomes) versus IR. A total of 1,868 limbs were available
for evaluation.
Study design and baseline characteristics
Study characteristics are given in Table 1. Revascularisation
was entirely endovascular in eight studies (1,284
limbs),15,17,18,21,22,24,25,29 via bypass surgery in six (508
limbs),16,19,20,23,27,28 and by both methods in one (76
limbs).26 A detailed breakdown of outcomes for endovas-
cular and bypass revascularisation were not available for
the latter study, which was therefore excluded from rele-
vant sensitivity analyses. Target vessel revascularisation
decision making was based on local policy/protocol (two
studies),20,23 at the discretion of the individual surgeon (two
studies),19,27 and on input from the multidisciplinary team
(two studies).15,18 Percutaneous transluminal angioplasty
was considered preferential to open surgery in three
studies.15,24,26 Bypass surgery was performed with a venous
conduit alone in ﬁve studies,16,19,26e28 while prosthetic
material was also used in two studies.20,23 Revascularisation
policy was speciﬁcally mentioned in ﬁve papers, preferen-
tially to the angiosome of the target tissue loss in
three,15,17,18 while the other two paid no regard to the
affected angiosome.16,27 Details of the target vessel revas-
cularised were given in six papers,18,20,24,26e28 although
one24 provided these data prior to propensity matching (see
Table 2). Compared with the IR group, patients undergoing
DR were more likely to undergo revascularisation to the
anterior tibial/dorsalis pedis artery, and less likely to un-
dergo revascularisation to the peroneal artery (p < .0001).
Assessment of the location of tissue loss and the classiﬁ-
cation of revascularisation as direct or not was undertaken
by a blinded reviewer in three studies.20,26,27 Propensity-
matched groups were provided in three papers,16,18,24
with equivalent baseline characteristics between groups.
For the remaining papers, baseline differences (i.e., patient
comorbidities, disease location/extent, and revascularisa-
tion mode) were signiﬁcantly different in the DR and IR
groups in two,19,28 while no signiﬁcant differences were
noted in ﬁve.20,22,26,27,29 Four papers included diabetic pa-
tients exclusively.15,17,24,29 There were six high-quality pa-
pers (NO score 6).16e18,23,24,27 GRADE quality assessment
was “low” or “very low” for all outcomes (Table 3), sug-
gesting that caution be taken when drawing conclusions
from the following data.
Outcomes
Data regarding wound healing were given in 11 papers
(1,121 limbs).15e17,19e21,23,24,26,27,29 Heterogeneity among
these studies was low (I2 ¼ 0%). Meta-analysis showed that
DR was associated with a signiﬁcantly greater wound
Figure 2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) chart detailing the identiﬁcation process for
eligible studies.
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p < .00001). This effect was maintained in all sensitivity
analysis (Fig. 3; Table 4), with a relatively consistent OR
(subgroup test for differences: I2 ¼ 0%) and low hetero-
geneity throughout.
Limb salvage rates were presented in 14 papers (1,775
limbs).16e29 Heterogeneity among these studies was high
(I2 ¼ 73%). Meta-analysis showed that DR was associated
with a signiﬁcantly improved limb salvage rate compared
with IR (OR 0.24, 95% CI 0.13e0.45, p < .0001). This effect
was maintained on sensitivity analysis for endovascular and
bypass revascularisation, for larger studies, and those
reporting follow-up at 1 year. However, this signiﬁcance was
lost for studies with propensity-matched groups and those
with a NO score 6, although only marginally for the latter
group (Table 4; subgroup test for differences: I2 ¼ 34.7%).
Heterogeneity varied within the sensitivity analysis from
0 to 87%.
Mortality rates were presented in eight papers (852
limbs).18,19,22,24,26e29 Heterogeneity among these studies
was relatively low (I2 ¼ 30%). Meta-analysis showed that
the method of revascularisation had no effect on mortality
rates (OR 0.77, 95% CI 0.50e1.19, p ¼ .24; Fig. 4). Similar
results were obtained on a variety of sensitivity analysis,with the exception of surgical bypass, where mortality rates
were better with DR (Table 4). Heterogeneity varied within
the sensitivity analysis from 0 to 53%.
Rates of reintervention were given in two papers (369
limbs).17,24 Heterogeneity among these studies was high
(I2 ¼ 70%). Meta-analysis showed that the method of
revascularisation had no effect on reintervention rates (OR
0.44, 95% CI 0.10e1.88, p ¼ .27).
DISCUSSION
This systematic review identiﬁed 15 cohort studies report-
ing on 1,868 limbs, comparing the effect of direct and in-
direct angiosomal revascularisation. Meta-analysis showed
that DR resulted in improved wound healing rates
compared with IR for both open and endovascular inter-
vention. Limb salvage rates were also improved in the DR
group compared with the IR group, although this signiﬁ-
cance was lost on sensitivity analysis of higher quality
studies. DR had no effect on long-term mortality or rein-
tervention rates.
Strengths and weaknesses
An extensive search for relevant studies was undertaken:
the majority of included papers were recent publications
Table 1. Demographic data and NewcastleeOttawa (NO) score of included studies.
First author (year) Retrospective/
prospective
Number of
centres
Consecutive
patients?
Vascular
intervention
Propensity-matched
groups
Follow up
(mo)
Patients
(n)
Limbs (n) DR (n) IR (n) Outcomes NO score
(max. 9)
Acin (2014)29 Retrospective Single Yes Endovascular No 12.0, 24.0 ND 85 46 39 1, 2, 3 5
Alexandrescu (2008)15 Retrospective Multiple ND Endovascular No 17.8 ND 102 85 17 1 4
Azuma (2012)16 Retrospective Single ND Bypass surgery Yes 24.0 ND 96 48 48 1, 2 9
Fossaceca (2013)17 Retrospective Single ND Endovascular No 17.5 201 201 167 34 1, 2, 4 7
Iida (2012)18 Retrospective Multiple Yes Endovascular Yes 18.0 236 236 118 118 2, 4, 5 8
Kabra (2013)19 Prospective Single ND Bypass surgery No 6.0 64 64 39 25 1, 2, 3 4
Kret (2014)27 Retrospective ND Yes Bypass surgery No ND 97 106 54 52 1, 2, 3 6
Lejay (2013)28 Retrospective Single Yes Bypass surgery No 12.0 54 58 36 22 2, 3 5
Neville (2009)20 Retrospective Single Yes Bypass surgery No ND ND 43 22 21 1 4
Osawa (2013)21 Retrospective Single ND Endovascular No ND 38 51 29 22 1, 2 4
Oshima (2012)22,a ND ND Yes Endovascular No 12.0 55 60 31 29 2, 3 4
Rashid (2013)23 Retrospective Single Yes Bypass surgery No 12.0 ND 141 66 75 1, 2 7
Soderstrom (2013)24 Retrospective Single Yes Endovascular Yes 12.0 ND 168 84 84 1 8
Soon (2012)25,a Retrospective ND ND Endovascular No ND 350 381 197 184 2 4
Varela (2010)26 Retrospective ND Yes Both No 12.0 70 76 45 31 1, 2, 3 5
Note. For outcomes: 1 ¼ wound healing, 2 ¼ limb salvage rates, 3 ¼ overall survival, 4 ¼ re-do/further procedure, 5 ¼ amputation free survival. DR ¼ direct revascularisation; IR ¼ indirect
revascularisation; ND ¼ no data.
a Conference proceedings (abstract).
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Table 2. Target for revascularisation (either to named artery or branch of) for direct (DR) and indirect revascularisation (IR), as given in ﬁve
papers. A signiﬁcantly greater number of limbs in the DR group had revascularisation to the anterior tibial (AT)/dorsalis pedis (DP), and
fewer to the peroneal artery when compared with the IR group (p < .0001, chi-square test).
First author (year) Direct revascularisation Indirect revascularisation
AT/DP Posterior tibial/
plantar arteries
Peroneal
artery
AT/DP Posterior tibial/
plantar arteries
Peroneal artery
Iida (2012)18,a 105 72 46 77 54 54
Kret (2014)27 27 26 1 15 6 31
Lejay (2013)28 31 3 2 17 3 2
Neville (2009)20 11 6 5 8 8 6
Varela (2010)26 37 6 2 10 1 20
Total 211 (55.5%) 113 (29.7%) 56 (14.7%) 127 (40.1%) 72 (23.1%) 113 (36.2%)
a Totals greater than limb number given owing to multiple angioplasties.
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are limitations to this meta-analysis, as all papers reviewed
were observational studies and most were retrospective.
According to their NO scores, fewer than half of the studies
were high quality.15e17,22,23,26 Only four papers clearly
deﬁned their practice regarding revascularisation,15e17,27 of
which two would preferentially attempt DR over IR.15,17 The
absence of standardised revascularisation decision-making
in the included papers, especially regarding if DR or IR
was attempted, is a serious source of bias, and makes it
difﬁcult to draw comparisons with an unselected vascular
population.35 Furthermore, the target vessel revascularised
was markedly different between the two groups, and out-
comes may simply be a result of different vessel selection.
Propensity-matched groups, and therefore higher quality
data, were only provided in three studies.16,18,24 Outcomes
for wound healing rates were maintained across sensitivity
analyses, but not for limb salvage. Heterogeneity was high
on certain sensitivity analyses. For these reasons, GRADE
assessment of the quality of evidence was either low or
very low. Only two papers provided data for reintervention
rates.
A further weakness is that no studies were adequately
powered randomised trials comparing DR and IR. The only
comparative study to date compared a nonangiosomal
(from 2001e05) and angiosomal (from 2005e10) revascu-
larisation policy in a single unit.30 In this unit, preferentially
revascularising according to the angiosome model (i.e.,
attempting DR where feasible) resulted in a signiﬁcant
improvement in wound healing and limb salvage, but not in
long-term survival, consistent with the results of this meta-
analysis.Table 3. Grading of Recommendations Assessment, Development and
bias was assessed for each included paper, and was assumed to be pres
analysed, or follow-up did not reach 12 months.
Outcome Limbs
(studies)
Risk of bias Inconsistency
Wound healing 1,121 (11) Serious No
Limb salvage 1,775 (14) Serious Serious
Mortality 852 (8) No No
Reintervention rate 369 (2) Serious Serious
Note. NA ¼ not applicable.Explanation of ﬁndings and implications for practice
The improved outcomes seen with DR compared with IR may
be explained by the absence of adequate interangiosomal
collaterals, typically seen in patients requiring tibial revas-
cularisation.6,36,37 In one of the few studies to examine this to
date, Varela et al.26 compared outcomes of DR to IR in pa-
tients with and without adequate collateral vessels as
demonstrated on angiography. DR demonstrated superior
outcomes to IR in those deemed as having absent collaterals.
However, when adequate collaterals were present, IR was
comparable to DR. The absence of collateral vessels may
prove vital in assessing which patients should be aggressively
targeted for DR. However, owing to the pattern of disease, DR
is occasionally technically impossible. Kret et al.27 and Rashid
et al.23 reported, respectively, that only 62% and 47% of pa-
tients had disease eligible for DR, while Alexandrescu et al.30
achieved DR in 80% of limbs. This difference may reﬂect se-
lection bias or different patient populations. Extensive tissue
loss or infection may preclude surgical access to gain DR even
when arteries are suitable for bypass.16 Often, disease
pattern mandates which vessel is amenable to intervention,
leaving the treating surgeon without a choice of DR versus IR
revascularisation. In this instance, identifying if the revascu-
larisation is direct or not is only of prognostic value. However,
when such an option is available, this meta-analysis suggests
that the angiosome concept should be considered when
planning for distal revascularisation, and DR should be uti-
lised preferentially to IR (when it is available) as a safe
option.38
A signiﬁcant number of studies employed tibial angio-
plasty. While long-term patency rates for endovascular
intervention in the tibial vessels may be low,39 anyEvaluation analysis, and assessment of quality of evidence. Risk of
ent when a nonconsecutive or nonpropensity-matched cohort was
Indirectness Imprecision Publication
bias
Overall quality
of evidence
No Serious Serious Very low
No Serious Serious Very low
No No NA Low
No No NA Very low
Figure 3. Direct (DR) versus indirect revascularisation (IR): forest plot for wound healing; all papers and sensitivity analyses. Note.
CI ¼ conﬁdence interval. M-H ¼ Mantel-Haenszel; NO ¼ NewcastleeOttawa.
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Figure 4. Direct (DR) versus indirect revascularisation (IR): forest plot for mortality rates. Note. CI ¼ conﬁdence interval; M-H ¼ Mantel-
Haenszel.
Table 4. Outcomes for direct (DR) and indirect revascularisation (IR), summary of ﬁndings.
Sensitivity analysis No. of studies
(total limbs)
DR (n) IR (n) HG I2
(%)
HG
p-value
OR (95% CI) Overall
effect Z
p-value
Wound healing
All studies 11 (1121) 683 438 0 .70 0.40 (0.29e0.54) 5.91 <.00001
Endovascular revascularisation 5 (605) 409 196 0 .65 0.34 (0.23e0.51) 5.28 <.00001
Bypass revascularisation 6 (516) 274 242 0 .61 0.49 (0.30e0.80) 2.88 .004
Larger studies 5 (718) 456 262 0 .67 0.43 (0.30e0.62) 4.52 <.00001
Propensity-matched groups 2 (264) 132 132 0 .87 0.38 (0.21e0.70) 3.09 .002
NO >5 5 (712) 419 293 0 .92 0.46 (0.32e0.68) 3.97 <.0001
1-year FU 6 (765) 454 311 0 .94 0.40 (0.28e0.58) 4.86 <.0001
Limb salvage
All studies 14 (1,775) 991 784 73 <.00001 0.24 (0.13e0.45) 4.45 <.0001
Endovascular revascularisation 7 (1,182) 672 510 85 <.00001 0.20 (0.08e0.54) 3.17 .002
Bypass revascularisation 6 (517) 274 243 0 .52 0.37 (0.21e0.67) 3.29 .001
Larger studies 6 (1,233) 686 547 87 <.00001 0.31 (0.11e0.87) 2.23 .03
Propensity-matched groups 3 (500) 250 250 0 .50 0.67 (0.40e1.11) 1.56 .12
NO >5 6 (948) 537 411 87 <.00001 0.28 (0.07e1.08) 1.85 .06
1-year FU 5 (663) 335 328 29 .22 0.48 (0.26e0.91) 2.27 .08
Mortality
All studies 8 (852) 452 400 30 .19 0.77 (0.50e1.19) 1.16 .24
Endovascular revascularisation 4 (539) 269 270 0 .73 1.12 (0.75e1.68) 0.55 .58
Bypass revascularisation 3 (237) 138 99 0 .61 0.35 (0.16e0.78) 2.59 .01
Larger studies 3 (510) 256 254 53 .12 0.78 (0.38e1.61) 0.66 .51
Propensity-matched groups 2 (404) 202 202 0 .91 0.13 (0.64e1.65) 0.12 .90
NO >5 3 (510) 256 254 53 .12 0.78 (0.38e1.61) 0.66 .51
1-year FU 5 (616) 314 302 0 .55 0.84 (0.57e1.23) 0.89 .37
Reintervention
All studies 2 (369) 251 118 70 .07 0.44 (0.10e1.88) 1.10 .27
Note. HG ¼ heterogeneity; OR ¼ odds ratio; CI ¼ conﬁdence interval; NO ¼ NewcastleeOttawa; FU ¼ follow-up.
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sufﬁcient for wound healing,4 especially in patients with
signiﬁcant comorbidities or who are deemed unsuitable for
surgical bypass.4,40,41 Presuming intervention is useful, this
meta-analysis suggests that endovascular DR improves
wound healing and limb salvage rates. Importantly, there
was no increase in adverse outcomes (mortality or rein-
tervention rates) with DR. Some units now perform multiple
angioplasties of tibial vessels, effectively performing DR and
IR simultaneously.39 There were no comparable data on this
technique, but angioplasties of more than one tibial vessel
result in improved outcomes compared with single-vessel
angioplasty.42 Theoretically, a combined DR and IR would
improve total pedal perfusion, and overcome any problems
with inadequate interangiosomal collateralisation.18On sensitivity analysis, DR was (nonsigniﬁcantly) less
beneﬁcial for bypass surgery compared with endovascular
treatment for both wound healing and limb salvage rates.
This may reﬂect the fact that open surgery was preferen-
tially chosen for ﬁt patients or when good outﬂow vessels
were present. Open IR is performed so selectively in the
presence of excellent collateralisation that outcomes would
be expected to approach DR. In contrast, IR may be
attempted endovascularly with disease deemed unsuitable
for bypass. This could result in a greater rate of failed IR,
making DR appear better when undertaken endovascularly
compared with open.
There is only one other published meta-analysis on this
topic.43 While our conclusions regarding the beneﬁt of DR
over IR are in agreement with those of Biancari and
96 D.C. Bosanquet et al.Juvonen,43 we performed a more extensive literature search
(1,319 vs. 45 initial search results), resulting in a larger
number of included studies (15 vs. nine). We undertook
GRADE analysis, which is vital for accurately weighing the
quality of presented evidence, along with sensitivity ana-
lyses showing that the ﬁnding for improved limb salvage
was not maintained and therefore must be interpreted with
caution. Finally, we analysed the target vessel revascu-
larised, and showed that DR was much more likely to utilise
the anterior tibial compared to IR.
CONCLUSION
This systematic review and meta-analysis suggests that
there may be a beneﬁt for patients undergoing DR
compared with IR in terms of superior wound healing. Limb
salvage may also be improved, although this effect was lost
on certain sensitivity analysis. Overall, there was no differ-
ence in mortality or reintervention rates with DR compared
with IR, although only two papers commented on reinter-
vention. These data suggest that the angiosome concept
should be considered when planning distal revascularisation
and that DR should be considered superior to IR, accepting
that such a choice is not always available. While generally
accepted for open surgery, this is the ﬁrst collated evidence
to support this during endovascular intervention.
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